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Evolution of Basic Activities of Daily Living Function in Older
Patients One Year After Transcatheter Aortic Valve Implantation
Dominic Bertschi, MD,* André Moser, PhD,† Stefan Stortecky, MD,‡ Marcel Zwahlen, PhD,§
Stephan Windecker, MD,‡ Thierry Carrel, MD,¶ Andreas E. Stuck, MD,* and
Andreas W. Schoenenberger, MD*
BACKGROUND/OBJECTIVES: To assess the course and
prediction of basic activities of daily living (ADL) function
in patients after transcatheter aortic valve implanta-
tion (TAVI).
DESIGN: This was a prospective cohort study.
SETTING: The setting was a single academic center in
Switzerland.
PARTICIPANTS: Participants included individuals aged
≥70 years (n = 330) undergoing TAVI.
MEASUREMENTS: A frailty index (based on geriatric
assessment) and cardiac risk scores (EuroSCORE, Society
of Thoracic Surgeons [STS] score) were determined in
patients before TAVI. Basic ADL function was measured
with patient or proxy interviews at baseline and 1-year fol-
low up. We used logistic regression models to investigate
the association between baseline factors and functional
decline.
RESULTS: At 1-year follow up, 229 (69.4%) of the
330 patients had stable or improved basic ADL function,
49 (14.8%) experienced a decline in basic ADL function,
and 52 (15.8%) died. The frailty index, but not cardiac risk
scores, significantly predicted decline in basic ADL function.
Among the 34 surviving very frail patients, 12 (35.3%)
experienced a functional status decline, and the remaining
22 (64.7%) had stable or improved functional status at
1-year follow up.
CONCLUSION: This study confirms that a frailty index,
and not cardiac risk scores, identifies patients at an
increased risk of functional status decline after TAVI. Iden-
tifying patients with a high frailty index before TAVI is clin-
ically relevant as these patients might benefit from targeted
geriatric management and rehabilitation after TAVI. How-
ever, based on current data, it is not justified to use infor-
mation on frailty status as the criterion for identifying
patients in whom TAVI might be futile. Although the prob-
ability of poor outcome is high, very frail patients also have
a high probability of favorable long-term functional out-
come. J Am Geriatr Soc 00:1-6, 2020.
Keywords: geriatric assessment; cognitive assessment;
aortic stenosis; functional status; risk stratification; futil-
ity; cardiac risk scores
INTRODUCTION
Transcatheter aortic valve implantation (TAVI) has rev-olutionized treatment for patients with symptomatic
severe aortic stenosis.1 Survival is approximately 85% in
older patients 1 year after TAVI, compared with approxi-
mately 50% for medical treatment alone.2,3 Clinically rele-
vant improvements in physical function and quality of life
have also been observed 1 year after TAVI.4-6
Despite these promising results, recent studies have
found that outcomes may be poor in selected groups of
patients, particularly in those who are very frail. Afilalo
et al. found that 20% of 807 survivors experienced a func-
tional decline 1 year after surgical or transcatheter aortic
valve replacement, with frailty being the strongest predictor
of functional deterioration.7 Another study analyzed 1-year
functional outcome in a subgroup of 22 very frail patients
who underwent TAVI.8 In this subgroup, functional trajec-
tory was poor or very poor in 15 patients, fair in seven
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patients, and good to excellent in none of the patients.
These findings question whether TAVI is justified in very
frail patients.9
However, current information on functional outcomes
in very frail patients after TAVI is based on small samples in
selected studies. Additional data on functional outcomes in
frail patients are therefore needed to assist clinicians in mak-
ing the best possible decisions about treatment. The purpose
of our study was to measure the evolution of functional
status in a larger cohort of frail patients 1 year after TAVI.
We chose to use basic activities of daily living (ADL) as a
measure of functional status, given the importance of this
functional domain for quality of life and autonomy in older
patients. We investigated the association of baseline factors,
including cardiac risk scores and frailty status, with the evo-
lution of functional outcomes in this cohort.
METHODS
Study Population
This was a prospective cohort study of patients 70 years
and older, with symptomatic, severe aortic stenosis, referred
for TAVI evaluation to Bern University Hospital, Switzerland,
between September 1, 2009 and June 30, 2013.10,11 Only
patients who underwent elective TAVI surgery were included,
and baseline and follow-up data were collected as part of the
Bern TAVI registry (NCT01368250). Patients were excluded
if they received other treatments, had TAVI performed as an
emergency procedure, lived abroad, refused baseline geriatric
assessment, or if the assessment was not completed due to
logistic reasons. Patients were also excluded if the time
between geriatric baseline examination and TAVI exceeded
3 months, or if the patient died before TAVI. All patients
who provided written informed consent received a baseline
geriatric assessment in addition to a cardiac evaluation. This
study complies with the Declaration of Helsinki and was
approved by the local ethics committee. TAVI was performed
within 3 months after completion of the cardiac and geriatric
assessments.
Data Collection
All participating patients received an extensive baseline car-
diac assessment during an in-hospital evaluation, and logis-
tic EuroSCORE and STS scores were calculated.12 Patients
also received a baseline geriatric assessment including a
Mini Mental State Exam (MMSE),13 a timed get up and go
test (TUG),14 the Mini Nutritional Assessment (MNA),15
self-reported basic16 and instrumental17 ADL, and ques-
tions about self-reported preclinical mobility disability.18
For basic ADL, each activity (eating and drinking, going to
toilet, dressing, personal hygiene, and moving indepen-
dently inside the house) was scored zero if a patient was
able to perform it independently and one if the patient had
difficulties and/or needed help from another person. We cal-
culated a frailty index score based on the following scheme:
2 points for an MMSE score <21; 1 point each for an
MMSE score between 21 and 26, TUG score ≥ 20 seconds,
MNA score <12, ≥1 limited basic ADL, ≥1 limited instru-
mental ADL, and self-reported preclinical mobility disabil-
ity (decreased frequency of climbing stairs or walking
200 m in the last 6 months). The frailty index score ranges
from 0 to 7 points, with a score ≥3 indicating frailty.11
At 1-year follow up, basic ADL function was obtained
by self-report interview in surviving patients. Functional
decline was defined as a difference of ≥1 point in basic ADL
score between baseline and follow up, an improvement as a
difference of ≤−1 point. If a patient lived in a long-term
care facility or was unable to answer the interview, a proxy
was interviewed.
Statistical Analysis
We describe the study population by frequencies (n), per-
centages (%), and medians with interquartile range (IQR).
We analyzed the decline of basic ADL from baseline to fol-
low up with logistic regression. All logistic models include
at least age and gender. To assess predictive information of
the risk scores and the components of the frailty index
score, we report likelihood ratio (LR) test statistics compar-
ing models including the risk scores with models that do
not. We report the difference of LR test statistics, to investi-
gate whether the frailty index (A) adds predictive informa-
tion to the cardiologic risk scores (B) (Null hypothesis: A +
B > A) and vice versa (Null hypothesis: A + B > B).19,20 We
quantified overall model performance using Nagelkerke’s
R2 (NR). NR ranges from 0 to 1, with higher values indi-
cating better model performance. To assess discriminative
ability, we use the c-statistics, derived from the area under
receiver operating characteristics curve (AUC), with a value
of 0.5 indicating random prediction and a value of 1 indicat-
ing perfect prediction.21 All reported P-values are two
sided. All continuous variables are a priori modeled as a
quadratic relationship. All statistical analyses were per-
formed in R 3.2.3 using packages rms and pROC.22-24
RESULTS
Patient Population at Baseline and 1-Year Follow Up
A total of 613 patients referred for TAVI received a
preintervention comprehensive baseline evaluation. Within
3 months of referral, 385 patients underwent an elective
TAVI. A total of 330 patients were enrolled in the study
(see Supplementary Figure S1). Table 1 presents
preintervention data for enrolled patients. At baseline,
82 patients were limited in performing one to four basic
ADLs. No patient exhibited limitations in all five basic
ADLs. During the follow-up period, 229 (69.4%) of the
330 patients had stable or improved basic ADL function,
49 (14.8%) experienced a decline in basic ADL function,
and 52 (15.8%) died.
Predictors of Functional Status Decline
Table 2 summarizes the results from logistic regression
models analyzing the prediction of functional status decline
with a priori selected baseline risk factors for surviving
patients. A model with the frailty index, adjusted for age
and gender, was strongly associated with a decline in basic
ADL from baseline to 1-year follow up (OR = 3.26, 95%
CI = 1.72, 6.16). This model showed the best model perfor-
mance (NR = 0.127) and the best discriminative ability (c-
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statistic = 0.71). In comparison, a model with the cardiac
risk scores showed no evidence of an association. The LR
χ2 value from a model with the frailty index was 22.27.
The combination of the frailty index and the EuroSCORE
showed no improvement in predictive ability and discrimi-
nation and only a slight improvement when the frailty
index was combined with the STS score (NR = 0.129, c-sta-
tistic = 0.72). The combination of the frailty index with the
EuroSCORE did not change the LR χ2 of 22.27 and
resulted only in a minimal change of the LR χ2 for the com-
bination with the STS score (22.58). Among the compo-
nents of the frailty index, cognitive impairment, mobility
impairment, and limitation in instrumental ADL were sig-
nificantly associated with 1-year basic ADL decline.
Functional Evolution According to Frailty Status
Figure 1 depicts the evolution of functional status from
baseline to 1 year follow up in surviving patients according
to the patients’ initial frailty status. Although the propor-
tion of surviving patients with a decline increased more
than threefold, from 11.6% in nonfrail patients to 35.3%
in very frail patients, it also demonstrates that a relevant
proportion of very frail persons actually experienced a
Table 1. Preintervention Baseline Characteristics of Patients
Characteristic
Patients surviving 1-year follow
up (n = 278)
Patients who died before 1-year follow
up (n = 52)
General characteristics
Age, years, median (IQR) 83.4 (5.5) 84.2 (6.4)
Female gender, n (%) 157 (56.5) 29 (55.8)
Body mass index, kg/m2, median
(IQR)
25.3 (5.4) 24.0 (5.1)
Number of comorbiditiesa, median
(IQR)
3.0 (2.0) 4.0 (2.0)b
Cardiac parameters
Dyspnea NYHA class III or IV,
n (%)
182 (65.5) 37 (71.2)
Angina CCS score III or IV, n (%) 38 (13.7) 5 (9.6)
Left ventricular ejection fraction, %,
median (IQR)
60.0 (20.0) 50.0 (25.0)b
Mean gradient aortic valve, mmHg,
median (IQR)
42.0 (21.0) 38.0 (24.5)
Aortic valve area, cm2, median
(IQR)
0.6 (0.3) 0.6 (0.3)
Comprehensive geriatric assessment parameters
Cognitive impairment (MMSE <27
points), n (%)
85 (30.6) 25 (48.1)b
Mobility impairment (TUG
≥20 seconds), n (%)
81 (29.1) 32 (61.5)b
At risk of malnutrition (MNA <12
points), n (%)
120 (43.2) 34 (65.4)b
Basic ADL ≥1 limitation, n (%) 62 (22.3) 20 (38.5)b
Instrumental ADL ≥1 limitation,
n (%)
181 (65.1) 35 (67.1)
Preclinical mobility disabilityc, n (%) 170 (61.1) 35 (67.1)
Risk scores
Frailty status: nonfrail (frailty index
<3), n (%)
146 (52.5) 15 (28.8)b
Frailty status: frail (frailty index 3 or
4), n (%)
98 (35.3) 18 (34.6)
Frailty status: very frail (frailty index
≥5), n (%)
34 (12.2) 19 (36.5)b
Logistic EuroSCORE, median (IQR) 18.1 (15.7) 28.1 (21.4)b
STS score, median (IQR) 5.6 (3.8) 7.3 (5.7)b
Abbreviations: ADL, activities of daily living; CCS, Canadian Cardiovascular Society; IQR, interquartile range; MMSE, Mini Mental State Exam; MNA,
Mini Nutritional Assessment; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons; TAVI, transcatheter aortic valve implantation; TUG,
timed get up and go test.
aExtracted from clinical records, based on a list of 10 chronic conditions.10
bSignificant group difference (P < .05) between surviving patients and patients who died based on chi-squared test or Kruskal-Wallis test.
cSelf-reported decreased frequency of walking 200 m or of climbing stairs during the 6 months before baseline.18
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favorable course of functional status. Among the 34 surviv-
ing patients with the highest level of frailty at baseline,
functional status improved in 14 (41.2%) and remained sta-
ble in eight (23.5%) patients. In contrast, improvement was
minimal in patients with an initially low frailty index due to
a ceiling effect (in patients with no ADL limitation at base-
line, improvement was not possible).
DISCUSSION
Almost 70% of the patients in this cohort survived with
unchanged or improved basic ADL function 1 year after
TAVI. In patients with preprocedural frailty, basic ADL
outcome was worse, but even in the subgroup of patients
with the highest level of frailty, 64.7% of surviving patients
had unchanged or improved basic ADL function at 1-year
follow up. The predictive analyses revealed that the frailty
index, but not established cardiac risk scores, correlated
with basic ADL function at 1-year follow up.
Our findings differ from those of a recent cohort
study.8 This study found poor or very poor 1-year func-
tional trajectories in the majority of patients who were very
frail before TAVI. Based on these findings, a Commentary
questioned whether functional outcomes justify a TAVI
intervention in these very frail patients.9 In contrast, our
study shows no evidence supporting the use of frailty to
determine the futility of TAVI. Based on the data of our
cohort, the majority of surviving patients in the subgroup
with the highest levels of frailty had stable or improved
ADL function 1 year after TAVI. There are several reasons
for these conflicting results. First, prevalence estimates of
the previous study may be unprecise because they were
based on a small subsample of 22 very frail patients
(corresponding to 15.4% of the total study population of
143 patients). In comparison, our subsample consisted of
53 very frail patients (corresponding to 16.1% of the total
study population of 330 patients). Second, the previous
study used a definition of function that included measures
of instrumental ADL, and these functional outcomes may
have been affected by socioeconomic factors not related to
health. In contrast, we measured basic ADL function, a
measure strongly related with health status, disability, and
the need for nursing home admission.16 Finally, the previ-
ous study used statistical modeling to identify functional
trajectories after TAVI and may have missed a possible tra-
jectory of functional improvement from a low functional
level at baseline.
The finding that a frailty index predicts basic ADL
function is consistent with previous research.25-27 However,
our finding that the addition of cardiac risk scores to frailty
Table 2. Prediction of Basic ADL Decline from Baseline to 1-Year Follow Up After TAVI in Older Patientsa
Risk Factor OR (95% CI) P-value LR χ 2 NR C-statistic
Comprehensive geriatric assessment parameters
Cognitive impairment (MMSE <27 vs ≥27) 2.91 (1.51–5.58) .001 18.51 0.106 0.68
Mobility impairment (TUG ≥20 vs <20s) 2.02 (1.05–3.90) .04 12.60 0.073 0.66
Malnutrition risk (MNA <12 vs 12 points) 1.81 (0.96–3.42) .07 11.70 0.068 0.65
Limitation in basic ADL (≥1 vs 0 limited activity) 1.31 (0.62–2.74) .48 8.82 0.052 0.64
Limitation in instrumental ADL (≥1 vs 0 limited
activity)
2.89 (1.33–6.25) .01 16.52 0.095 0.65
Preclinical mobility disability (disability vs no
disability)
1.62 (0.83–3.19) .16 10.38 0.060 0.64
Single risk scores
Frailty index (per IQR increase, 3 points) 3.26 (1.72–6.16) <.001 22.27 0.127 0.71
Logistic EuroSCORE (per IQR increase, 15.7
points)
0.98 (0.64–1.50) .94 8.34 0.049 0.61
STS score (per IQR increase, 3.8 points) 1.16 (0.86–1.57) .33 9.24 0.054 0.63
Combination of Frailty index with EuroSCORE
Combined model (frailty index (A) and EuroSCORE
(B))
NA <.001b 22.27 0.127 0.71
Frailty index (per IQR increase, 3 points) 3.26 (1.72–6.16) <.001 0.00c
Logistic EuroSCORE (per IQR increase, 15.7
points)
0.99 (0.64–1.54) .97 13.93c
Combination of Frailty index with STS Score
Combined model (frailty index (A) and STS score
(B))
NA <.001b 22.58 0.129 0.72
Frailty index (per IQR increase, 3 points) 3.21 (1.69–6.11) <.001 0.31c
STS score (per IQR increase, 3.8 points) 1.09 (0.80–1.49) .57 13.34c
Abbreviations: ADL, activities of daily living; CI, confidence interval; IQR, interquartile range; LR, likelihood ratio chi-squared test statistic; MMSE, Mini
Mental State Exam; MNA, Mini Nutritional Assessment; NA, not applicable; NR, Nagelkerke’s R2; OR, odds ratio; STS, Society of Thoracic Surgeons;
TAVI, transcatheter aortic valve implantation; TUG, timed get up and go test.
aAll models were adjusted for age and gender and were based on the analysis of the sample of patients surviving the 1-year follow up (N = 278).
bP-value from Wald test of the joint null hypotheses: (A) = (B) = 0 (log odds scale).
cDifference of LR of nested model (A + B) minus single risk score model (A) or (B), that is, the value of the nested LR explained by the listed single risk score
(A) or (B).
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index scores does not improve prediction of functional out-
come has not been previously described. The findings of
our study suggest that predictors of mortality and function
are different as previous research found strong evidence
that both a frailty index and an established cardiac risk
score independently predict mortality 1 year after TAVI.10
Our observation that cognitive impairment was signifi-
cantly associated with basic ADL outcome suggests that
cognitive assessment should be part of routine frailty assess-
ment in older patients referred for a TAVI evaluation.
Screening for frailty with a tool measuring physical function
alone, as has been recently suggested,28 may be suboptimal
for predictive purposes.
Our study has several limitations. First, this is a single-
site study, and therefore, generalizability is limited. Addi-
tional data are needed from large multicenter studies using
common methods to assess preinterventional frailty level
based on geriatric assessment and functional outcomes
1 year after TAVI, including basic ADL function. Second,
our function data are based on single baseline and 1-year
follow-up measurements, and not on repeated measure-
ments. In addition, our data reflect self-report, and not
observed, performance. Finally, prevalence rates in sub-
groups should be interpreted with caution given the small
sample sizes. Study strengths include a low refusal rate
(9.3%) among eligible patients and no missing data at
1-year follow up.
This study has important clinical implications. As frail
patients are at increased risk of unfavorable outcomes after
TAVI, targeted strategies for optimizing preintervention
(e.g., prehabilitation) and postintervention management
should be used to reduce adverse outcomes and improve
survival and functional trajectory in these patients. From
this perspective, the approach of measuring frailty with ele-
ments of geriatric assessment is advantageous, in that the
findings of geriatric assessment can be used both for mea-
suring risk and for subsequent geriatric management.29,30
In conclusion, a frailty index might serve as a basis for
targeted geriatric management, but in this study, it did not
identify a subgroup of patients in whom TAVI might have
to be considered futile.
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